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Abstract
Introduction: There are a number of pre-analytical and analytical factors, which cause false results in the complete blood count. The present case 
identifies cold agglutinins as the cause for the mismatch between hematocrit and hemoglobin values.
Materials and methods: 70-year old female patient had a history of cerebrovascular diseases and rheumatoid arthritis. During routine laboratory 
examination, the patient had normal leukocyte and platelet counts; however, the hemoglobin (Hb: 105 g/L) and hematocrit (HCT: 0.214 L/L) results 
were discordant. Hemolysis, lipemia and cold agglutinin were evaluated as possible reasons for the mismatch between hematocrit and hemoglobin 
values.
Results: First blood sample was slightly hemolysed. Redrawn sample without hemolysis or lipemia was analyzed but the mismatch became even 
more distinct (Hb: 104 g/L and HCT: 0.08 L/L). In this sample, the titration of the cold agglutinin was determined and found to be positive at 1:64 
dilution ratios. After an incubation of the sample at 37°C for 2 hours, reversibility of agglutination was observed.
Conclusion: We conclude that cold agglutinins may interfere with the analysis of erythrocyte and erythrocyte-related parameters (HCT, MCV, MCH 
and MCHC); however, Hb, leukocyte and platelet counts are not affected.
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The use of automated hematology analyzers to 
examine complete blood count (CBC) is very com-
mon. The CBC is applied to diagnose anemia, to 
identify acute and chronic illness, bleeding ten-
dencies and white blood cell disorders by both 
general practitioners and other medical special-
ties. There are a number of pre-analytical and ana-
lytical factors that cause false CBC results. Red 
blood cell (RBC) counts, hemoglobin (Hb), mean 
cell volume (MCV), white blood cell (WBC) count 
and platelet (PLT) count are parameters measured 
by hematology analyzers that are affected by spu-
rious values in several situations. These situations 
commonly include the agglutination in the pres-
ence of ethylenediamine tetra-acetic acid (EDTA), 
insufficiently lysed RBC, erythroblast, platelet ag-
gregates, cryoglobulins, agglutinins, lipids, hemol-
ysis, and elevated WBC counts (1).
In the present case, we evaluated cold agglutinins 
as a reason for the mismatch between hematocrit 
and hemoglobin values. There are several case 
studies associated with cold agglutinins; however, 
these studies have been generally presented in a 
clinical perspective. Laboratory findings were also 
not sufficiently available in these studies. Only few 
cases have recently drawn attention to the impor-
tance of pre-analytical affect of cold agglutinins 
on CBC results (2,3). To our knowledge, the present 
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study is also a unique case report of spurious CBC 
results associated with cold agglutinins using the 




An anticoagulated blood sample (K3EDTA, 2 mL, 
Golden Vac-Tube, GongDong Medical Technology 
Co., Zhejiang, China) drawn from a 70-year old fe-
male patient was analyzed during routine labora-
tory examination. Patient had WBC 7.1 x 109/L and 
PLT count 327 x 109/L; however, hemoglobin (Hb: 
105 g/L) and hematocrit (HCT: 0.214 L/L) results 
were discordant [if Hb value (mg/dL) is multiplied 
by three, it gives ± 3 HCT value (%)], as shown in 
Table 1 (Sample 1). Blood samples have been trans-
ferred from patient’s home to our laboratory after 
routine examination by a family physician. Patient 
had a history of cerebrovascular diseases and rheu-
matoid arthritis.
We first suspected hemolysis. When the tube with 
K3EDTA was centrifuged at 500 x g for 3 minutes, 
slight hemolysis appeared. Thus, to rule out prob-
lems with blood sample drawing, the physician and 
phlebotomist were informed to redraw the tube 
with K3EDTA. One tube with K3EDTA was drawn by 
home health services in non-fasting state and a 
CBC was run, but the results were not corrected; in 
fact, the mismatch became even more distinct (Hb: 
104 g/L and HCT: 0.08 L/L) (Sample 2 in Table 1). 
Moreover, the sample had not hemolysis or lipemia. 
We then suspected cold agglutinin. In this sample, 
the titer of cold agglutinin was determined and a 
peripheral blood smear was also prepared.
The determination of cold agglutinin titer
The titer of cold agglutinin was determined ac-
cording to a previously described method (4). Ten 
tubes were prepared to determine the titration of 
cold agglutinins. 1.5 mL of physiologic saline was 
placed in tube 1 and 1.0 mL of physiologic saline in 
tubes 2-10. 0.5 mL of patient’s serum was added to 
tube 1, mixed and 1 mL of the mix was transferred 
to tube 2, from which 1.0 mL was then transferred 
to tube 3; the process was reiterated until tube 9 
(tube 10 served as a cell control). By this method, 
dilutions from 1:4 to 1:1024 were obtained. 0.1 mL 
of patient’s own erythrocyte suspension (2-5%) 
was added to each tube, and the contents were 
mixed by vigorously shaking and then placed in 
racks at 4 °C overnight. Tubes were removed from 
the refrigerator and read immediately. Readings 
were made by shaking the tube 3-5 times, firmly 
enough to make a silk-like suspension in negative 
tests. The agglutination degree was recorded as 
1+ to 5+, 1+ representing just visible agglutination 
and 5+, a solid clump of cells. After reading, tubes 
were placed at 37 °C for 2 hours and re-visualized.
Results
The titration of the cold agglutinin was found to 
be 4+ at 1:4 dilution ratio and 1+ at 1:64 dilution 
ratios. After incubation at 37 °C for 2 hours, revers-
ibility of agglutination was observed. Thus, agglu-
tination was confirmed as cold agglutinin.
As shown in Figure 1A, when the blood smear was 
examined under the microscope, clusters of eryth-
rocytes were observed in each field.
After obtaining these findings, an expert phlebot-
omist and specialist of medical biochemistry visit-
ed the patient to draw blood at her home. The 
drawn specimen in non-fasting state was immedi-
ately transferred to the laboratory. During transfer, 
the specimen had not been exposed to the cold. 
The flat plastic container (500 mL) had been filled 
with water warmed to approximately 40 °C. The 
specimen had been placed in this hot plastic con-
tainer and transferred inside the Styrofoam box. 
The K3EDTA tube was immediately run on the he-
matology analyzer. It seemed that all the CBC re-
sults were valid (Sample 3 in Table 1). Clusters of 
erythrocyte were not observed in the blood smear 
prepared from this sample (Figure 1B). Subsequent-
ly, this specimen was placed at 4 °C for 30 min, and 
re-analyzed. Although leukocyte and platelet val-
ues were not changed, a mismatch between HCT 
and Hb was again observed (Sample 3a in Table 1). 
The specimen was then stored at room tempera-
ture for 1-hour and re-analyzed, but the results re-
mained the same (Sample 3b in Table 1).
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Discussion
Cold agglutinins are antibodies that are usually 
specific for I antigen, an erythrocyte surface car-
bohydrate macromolecule. Cold agglutinins bind 
to the erythrocyte surface antigen at a tempera-
ture optimum of 0-4 °C, which causes agglutina-
tion of erythrocytes and, thereby, impaired micro-
circulation ranging from moderate acrocyanosis to 
severe Raynaud’s phenomenon (5). The antigen-
antibody complex also induces the classical com-
plement pathway, resulting in extravascular hemo-
lysis. The physiologic cooling of blood in periph-
eral vessels is usually sufficient to cause hemolysis 
and circulatory symptoms in patients with high 
thermal amplitude of cold agglutinins (6). The clin-
ical effects of cold agglutinins are dependent on 
both the titer and the thermal amplitude of anti-
body (7).
Sample 1 Sample 2 Sample 3 Sample 3a Sample 3b
RBC (x 1012/L) 1.86 0.65 3.26 0.45 0.46
Hb (g/L) 105 104 100 109 105
HCT (L/L) 0.214 0.080 0.298 0.058 0.061
MCV (fL) 115 123 91 127 133
MCH (pg) 56.4 159.8 30.8 239.9 229
MCHC (g/L) 491 1295 337 1884 1724
PLT (x 109/L) 327 364 324 325 328
WBC (x 109/L) 7.1 6.9 7.7 7 6.8
Sample 1: First sample with slight hemolysis; Sample 2: The sample transferred using the routine method without 
hemolysis or lipemia; Sample 3: The sample transferred without exposition to cold and analysed immediately; 
Sample 3a: Sample 3 analysed after placing the sample at 4 °C for 30 min; Sample 3b: Sample 3 analysed after 
placing the sample at room temperature for 1 hour.
RBC – red blood cells; Hb – hemoglobin; HCT – hematocrit; MCV - mean corpuscular volume; MCH - mean corpuscular 
hemoglobin; MCHC - mean corpuscular hemoglobin concentration; PLT – platelets; WBC – white blood cells.
Table 1. The results of CBC analysis in different samples.
Figure 1. Peripheral blood smear, May-Grunwald-Giemsa stain, 1000x. A: Redrawn first sample with clusters of erythrocyte, B: Sam-
ple transferred without exposition to cold.
A B
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Cold agglutinins are rare and only low titers can be 
found in the serum of healthy individuals. Cold ag-
glutinins may be monoclonal or polyclonal. Mono-
clonal antibodies are usually found in patients with 
idiopathic forms of cold agglutinin disease or lym-
phoproliferative disorders. Polyclonal antibodies 
usually appear after infection, most often with 
Mycoplasma pneumonia, Ebstein-Barr virus or cy-
tomegalovirus (7).
Cold agglutinins can cause hemolysis in patients 
undergoing cardiac surgery during a hypothermic 
cardiopulmonary bypass. Screening for cold ag-
glutinin in all patients is not recommended; how-
ever, it can be useful in specific patient groups (8).
In the presence of cold agglutinins, we found de-
creased HCT and elevated MCV values. Hemoglob-
in concentration was unaffected by cold aggluti-
nins, thereby, calculated MCH and MCHC values 
were prominently elevated. Leukocyte and plate-
let counts were also found to be unaffected by 
cold agglutinins. In the present case, the analysis 
of CBC was performed on ABX Pentra 80 hematol-
ogy analyzer. RBC is measured by an electronic im-
pedance variation principle on ABX Pentra 80. MCV 
and HCT are calculated directly from the RBC his-
togram. The impedance method of counting and 
sizing cells is based on measurable changes in 
electrical resistance produced by non-conductive 
cells suspended in conductive isotonic electrolyte 
solution. This electrical resistance is manifested as 
a pulse that has a height directly proportional to 
the cell size. Red blood cells, platelets and leuko-
cytes are counted and sized according to the total 
number and heights of produced pulses (9). Cells 
between 30 to 300 fL are considered and counted 
as red blood cells on Horiba ABX Pentra. The micro-
aggregates of erythrocyte are counted as single 
cells and large clumps of cells are excluded from 
the count, which lead to decreased RBC count (9). 
These abnormal RBC values will lead to abnormal 
MCV and HCT results.
We met with the present case in winter. Therefore, 
the cold agglutinin forming might be the result of 
the fact that blood samples were exposed to cold 
weather during transfer from patient’s home to 
our laboratory. When the patient’s previous results 
were reviewed, CBC results were found to be valid. 
This is most likely due to drawing the blood sam-
ples at the hospital, without exposure to cold. In 
addition, we found that CBC results were valid if 
the blood drawn from the patient was immediate-
ly transferred to the laboratory without being ex-
posed to cold.
The interference of cold agglutinin on RBC and 
HCT results has previously been reported using an 
older automated hematology analyzer (10,11). It is 
seems that cold agglutinins can still cause artifac-
tual changes on RBC and related parameters. This 
might be due to the counting of RBC by the im-
pedance method, which is widespread among he-
matology analyzers produced different manufac-
tures. In accordance with our case report, Kakkar 
(2) revealed spurious CBC results due to cold ag-
glutinins on Advia 60 (Bayer diagnostics) hematol-
ogy analyzer. In his report of two cases, he report-
ed HCT to be spuriously low and discordant with 
Hb. MCV, MCH and MCHC values have also been 
found to be elevated.
Similarly, Breuer et al. (3) reported four patients 
with cold agglutinins whose RBC parameters de-
scribed were incompatible and spurious. They 
showed that cold agglutinins caused artificially de-
creased red blood cell counts and increased MCV 
and MCHC in the automated Coulter STKS hema-
tology analyzer. It was also noted that leukocyte 
and platelet counts remained unchanged. In a 
more recent case, Reddy et al. (12) reported elevat-
ed MCHC and MCV in a 12-year-old girl with mixed 
autoimmune hemolytic anemia.
The in vitro phenomenon of cold agglutination re-
sults in a spurious increase in MCV and MCHC and 
a decrease in the RBC count given by automated 
hematology analyzer; however, different findings 
have been reported in some clinical case reports.
In a 55-year old woman with a history of rheuma-
toid arthritis, Bizzaro et al. (13) presented in vitro 
platelet clumping due to EDTA-dependent autoan-
tibodies and RBC agglutination due to cold agglu-
tinins. Although they observed elevated MCHC in 
laboratory examination, the MCV value was re-
ported as normal. In another study, Lee et al. (14) 
identified cold agglutinin in a case of 75-year old 
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woman patient with non-Hodgkin’s lymphoma. 
They identified RBC agglutination related to cold 
agglutinins; however, a normal MCHC value was 
reported. Laboratory methodology and findings 
were, unfortunately, not obtained from these stud-
ies. Therefore, a satisfactory comparison could not 
be done.
In conclusion, cold agglutinins interfere with the 
analysis of RBC and RBC-related parameters (HCT, 
MCV, MCH and MCHC); however, Hb, WBC and PLT 
counts are not affected. In addition, the presence 
of cold agglutinins is easily displayed by the cold 
agglutinin titer test. It is also visible in a blood 
smear. Also, the effect of cold agglutinin on CBC 
results may be prevented if the blood drawn from 
the patient is immediately transferred to the labo-
ratory without exposure to cold. Lastly, clinicians 
should be aware of the fact that anemia diagnosis 
based on low HCT alone may be misleading.
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